$1.28-0.04 (-3.03%)
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America.
Firefly Neuroscience, Inc. in the Technology sector is trading at $1.28 with a market capitalization of $23M. The stock is currently 65% below its 52-week high of $3.63, remaining 25.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 24 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $485,000β | $412,000β | $388,000β | $299,000β | $43,000 |
| Gross Profit | $221,000β | $182,000β | $146,000β | $274,000β | $43,000 |
| Operating Income | -$2.01Mβ | -$2.40Mβ | -$2.50Mβ | -$1.63Mβ | -$2.06M |
| Net Income | -$2.00Mβ | -$2.48Mβ | -$2.64Mβ | -$1.83Mβ | -$12.93M |
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the huma...